Optimal radiotherapy dose in cervical esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy: A population based study.

Thorac Cancer · 2021 · PMC8287021 · PMID 34028200

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significancep = 0.06so close (0.05 < p ≤ 0.1)

DISCUSSION In this population‐based nonrandomized study on C‐ESqCC patients treated with definitive concurrent chemoradiotherapy, there was a trend in favor of high radiotherapy dose versus standard dose with borderline significance ( p = 0.06) in the primary analyses (PSW), although significance ( p = 0.03) was observed in the supplementary analysis (PSM).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.